These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


461 related items for PubMed ID: 15083251

  • 1. Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?
    Bateman DN, Chick J, Good AM, Kelly CA, Masterton G.
    Eur J Clin Pharmacol; 2004 May; 60(3):221-4. PubMed ID: 15083251
    [Abstract] [Full Text] [Related]

  • 2. Antidepressant use during pregnancy. FPIN’s clinical inquiries.
    Patel BN, Beste J, Blackwell JC.
    Am Fam Physician; 2011 May 15; 83(10):1211-5. PubMed ID: 21568258
    [No Abstract] [Full Text] [Related]

  • 3. Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
    Thase ME, Nierenberg AA, Vrijland P, van Oers HJ, Schutte AJ, Simmons JH.
    Int Clin Psychopharmacol; 2010 Jul 15; 25(4):189-98. PubMed ID: 20531012
    [Abstract] [Full Text] [Related]

  • 4. Re: Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
    Al-Adwani A.
    Can J Psychiatry; 2005 Nov 15; 50(13):877; author reply 877-8. PubMed ID: 16483124
    [No Abstract] [Full Text] [Related]

  • 5. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
    Banzi R, Cusi C, Randazzo C, Sterzi R, Tedesco D, Moja L.
    Cochrane Database Syst Rev; 2015 May 01; 2015(5):CD011681. PubMed ID: 25931277
    [Abstract] [Full Text] [Related]

  • 6. Antidepressants for insomnia in adults.
    Everitt H, Baldwin DS, Stuart B, Lipinska G, Mayers A, Malizia AL, Manson CC, Wilson S.
    Cochrane Database Syst Rev; 2018 May 14; 5(5):CD010753. PubMed ID: 29761479
    [Abstract] [Full Text] [Related]

  • 7. Comparative toxicity of citalopram and the newer antidepressants after overdose.
    Kelly CA, Dhaun N, Laing WJ, Strachan FE, Good AM, Bateman DN.
    J Toxicol Clin Toxicol; 2004 May 14; 42(1):67-71. PubMed ID: 15083939
    [Abstract] [Full Text] [Related]

  • 8. Mirtazapine versus selective serotonin reuptake inhibitors.
    Thompson C.
    J Clin Psychiatry; 1999 May 14; 60 Suppl 17():18-22; discussion 46-8. PubMed ID: 10446737
    [Abstract] [Full Text] [Related]

  • 9. An overview of the clinical efficacy of mirtazapine.
    Benkert O, Muller M, Szegedi A.
    Hum Psychopharmacol; 2002 Jun 14; 17 Suppl 1():S23-6. PubMed ID: 12404666
    [Abstract] [Full Text] [Related]

  • 10. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.
    Bauer M, Tharmanathan P, Volz HP, Moeller HJ, Freemantle N.
    Eur Arch Psychiatry Clin Neurosci; 2009 Apr 14; 259(3):172-85. PubMed ID: 19165525
    [Abstract] [Full Text] [Related]

  • 11. Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
    Benazzi F.
    Can J Psychiatry; 2005 Mar 14; 50(3):184. PubMed ID: 15830829
    [No Abstract] [Full Text] [Related]

  • 12. Noradrenergic and serotonergic modulation to treat vasomotor symptoms.
    Albertazzi P.
    J Br Menopause Soc; 2006 Mar 14; 12(1):7-11. PubMed ID: 16513016
    [Abstract] [Full Text] [Related]

  • 13. [Applications and safety of modern antidepressants in patients with liver diseases].
    Dubarek W, Kucia K.
    Wiad Lek; 2007 Mar 14; 60(1-2):28-33. PubMed ID: 17607965
    [Abstract] [Full Text] [Related]

  • 14. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
    Cipriani A, Zhou X, Del Giovane C, Hetrick SE, Qin B, Whittington C, Coghill D, Zhang Y, Hazell P, Leucht S, Cuijpers P, Pu J, Cohen D, Ravindran AV, Liu Y, Michael KD, Yang L, Liu L, Xie P.
    Lancet; 2016 Aug 27; 388(10047):881-90. PubMed ID: 27289172
    [Abstract] [Full Text] [Related]

  • 15. Safety and tolerability of the new antidepressants.
    Nelson JC.
    J Clin Psychiatry; 1997 Aug 27; 58 Suppl 6():26-31. PubMed ID: 9227670
    [Abstract] [Full Text] [Related]

  • 16. Hyponatremia associated with selective serotonin reuptake inhibitors, mirtazapine, and venlafaxine in Korean patients with major depressive disorder.
    Jung YE, Jun TY, Kim KS, Bahk WM.
    Int J Clin Pharmacol Ther; 2011 Jul 27; 49(7):437-43. PubMed ID: 21726494
    [Abstract] [Full Text] [Related]

  • 17. Serotonin syndrome produced by a combination of venlafaxine and mirtazapine.
    Dimellis D.
    World J Biol Psychiatry; 2002 Jul 27; 3(3):167. PubMed ID: 12478883
    [No Abstract] [Full Text] [Related]

  • 18. Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study.
    Brent DA, Emslie GJ, Clarke GN, Asarnow J, Spirito A, Ritz L, Vitiello B, Iyengar S, Birmaher B, Ryan ND, Zelazny J, Onorato M, Kennard B, Mayes TL, Debar LL, McCracken JT, Strober M, Suddath R, Leonard H, Porta G, Keller MB.
    Am J Psychiatry; 2009 Apr 27; 166(4):418-26. PubMed ID: 19223438
    [Abstract] [Full Text] [Related]

  • 19. Lack of significant toxicity after mirtazapine overdose: a five-year review of cases admitted to a regional toxicology unit.
    Waring WS, Good AM, Bateman DN.
    Clin Toxicol (Phila); 2007 Apr 27; 45(1):45-50. PubMed ID: 17357381
    [Abstract] [Full Text] [Related]

  • 20. Relief of SSRI-induced sexual dysfunction with mirtazapine treatment.
    Farah A.
    J Clin Psychiatry; 1999 Apr 27; 60(4):260-1. PubMed ID: 10221289
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.